Table 3 Average values of PCS and MCS (the two main variables in the SF-36v2 questionnaire), according to gender, social class, HbA1c level, hospitalization and complications

PCS

Sex

All

45.22

9.82

0.0046

Female

43.65

10.14

Male

47.43

8.95

HAS

No

49.41

8.06

0.0 173

Yes

44.65

9.92

DLP

No

47.16

7.79

0.2267

Yes

44.74

10.28

Retinopathy

No

46.03

9.75

0.0900

Yes

43.71

9.84

Nephropathy

No

45.94

9.60

0.2242

Yes

44.21

10.09

Neuropathy

No

46.80

9.33

0.0 160

Yes

43.43

10.10

Macroangiopathy

No

45.61

9.84

0.4232

Yes

44.45

9.85

Hospitalization

No

46.11

9.51

0.0002

Yes

37.34

9.20

HbA1c

1 (4%-6%)

43.90

10.47

0.0345

2 (6.1%-6.5%)

43.72

12.79

3 (6.6%-7.5%)

47.60

9.33

4 (7.6%-8.5%)

41.92

9.98

5 (>8.5%)

46.03

8.95

IBGE* categories

1 (>20 MW)

44.71

12.06

0.9547

2 (10-20 MW)

46.99

8.45

3 (4-10 MW)

45.49

9.33

4 (2-4 MW)

45.25

10.25

5 (<2 MW)

44.16

9.27

MCS

Sex

All

47.51

13.31

0.0034

Female

45.11

14.10

Male

50.83

11.42

HAS

No

46.53

9.90

0.3 155

Yes

47.65

13.73

DLP

No

47.02

12.44

0.5584

Yes

47.64

13.61

Retinopathy

No

47.16

13.09

0.5614

Yes

48.18

13.80

Nephropathy

No

47.10

12.81

0.3792

Yes

48.10

14.07

Neuropathy

No

48.30

12.69

0.4516

Yes

46.62

14.00

Macroangiopathy

No

47.04

13.10

0.3279

Yes

48.64

13.22

Internment

No

48.41

12.81

0.0 107

Yes

39.42

15.33

HbA1c

1 (4%-6%)

48.44

13.79

0.0964

2 (6.1%-6.5%)

49.82

11.28

3 (6.6%-7.5%)

50.66

12.08

4 (7.6%-8.5%)

48.23

13.63

5 (>8.5%)

44.31

13.92

IBGE categories*

1 (>20 MW)

51.89

8.46

0.3877

2 (10-20 MW)

50.44

9.94

3 (4-10 MW)

49.71

13.06

4 (2-4 MW)

46.66

12.15

5 (<2 MW)

45.47

14.09